2022 ICD-10-CM Code L51.1
Stevens-Johnson syndrome
Code Classification
L51.1 is a billable diagnosis code used to specify a medical diagnosis of stevens-johnson syndrome. The code L51.1 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code L51.1 might also be used to specify conditions or terms like acute erythematous eruption of skin, acute erythematous eruption of skin, drug-induced stevens-johnson syndrome, stevens-johnson syndrome, stevens-johnson syndrome , stevens-johnson syndrome, toxic epidermal necrolysis spectrum, etc.
Entries in the Index to Diseases and Injuries with references to L51.1
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code L51.1 are found in the index:
- - Ectodermosis erosiva pluriorificialis - L51.1
- - Erythema, erythematous (infectional) (inflammation) - L53.9
- - multiforme (major) (minor) - L51.9
- - bullous, bullosum - L51.1
- - conjunctiva - L51.1
- - multiforme (major) (minor) - L51.9
- - Stevens-Johnson disease or syndrome - L51.1
- - Syndrome - See Also: Disease;
- - Stevens-Johnson syndrome - L51.1
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Acute erythematous eruption of skin
- Acute erythematous eruption of skin
- Drug-induced Stevens-Johnson syndrome
- Stevens-Johnson syndrome
- Stevens-Johnson syndrome
- Stevens-Johnson syndrome, toxic epidermal necrolysis spectrum
- Stevens-Johnson syndrome, toxic epidermal necrolysis spectrum
Clinical Information
- STEVENS JOHNSON SYNDROME-. rare cutaneous eruption characterized by extensive keratinocyte apoptosis resulting in skin detachment with mucosal involvement. it is often provoked by the use of drugs e.g. antibiotics and anticonvulsants or associated with pneumonia mycoplasma. it is considered a continuum of toxic epidermal necrolysis.
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code L51.1 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
MS-DRG | MS-DRG Title | MCD | Relative Weight |
---|---|---|---|
595 | MAJOR SKIN DISORDERS WITH MCC | 09 | 2.0121 |
596 | MAJOR SKIN DISORDERS WITHOUT MCC | 09 | 0.9892 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert L51.1 to ICD-9 Code
- 695.13 - Stevens-Johnson syndrome
Information for Patients
Skin Conditions
Your skin is your body's largest organ. It covers and protects your body. Your skin
- Holds body fluids in, preventing dehydration
- Keeps harmful microbes out, preventing infections
- Helps you feel things like heat, cold, and pain
- Keeps your body temperature even
- Makes vitamin D when the sun shines on it
Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance.
NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases
[Learn More in MedlinePlus]
Stevens-Johnson syndrome/toxic epidermal necrolysis
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a severe skin reaction most often triggered by particular medications. Although Stevens-Johnson syndrome and toxic epidermal necrolysis were once thought to be separate conditions, they are now considered part of a continuum. Stevens-Johnson syndrome represents the less severe end of the disease spectrum, and toxic epidermal necrolysis represents the more severe end.
SJS/TEN often begins with a fever and flu-like symptoms. Within a few days, the skin begins to blister and peel, forming very painful raw areas called erosions that resemble a severe hot-water burn. The skin erosions usually start on the face and chest before spreading to other parts of the body. In most affected individuals, the condition also damages the mucous membranes, including the lining of the mouth and the airways, which can cause trouble with swallowing and breathing. The painful blistering can also affect the urinary tract and genitals. SJS/TEN often affects the eyes as well, causing irritation and redness of the conjunctiva, which are the mucous membranes that protect the white part of the eye and line the eyelids, and damage to the clear front covering of the eye (the cornea).
Severe damage to the skin and mucous membranes makes SJS/TEN a life-threatening disease. Because the skin normally acts as a protective barrier, extensive skin damage can lead to a dangerous loss of fluids and allow infections to develop. Serious complications can include pneumonia, overwhelming bacterial infections (sepsis), shock, multiple organ failure, and death. About 10 percent of people with Stevens-Johnson syndrome die from the disease, while the condition is fatal in up to 50 percent of those with toxic epidermal necrolysis.
Among people who survive, long-term effects of SJS/TEN can include changes in skin coloring (pigmentation), dryness of the skin and mucous membranes (xerosis), excess sweating (hyperhidrosis), hair loss (alopecia), and abnormal growth or loss of the fingernails and toenails. Other long-term problems can include impaired taste, difficulty urinating, and genital abnormalities. A small percentage of affected individuals develop chronic dryness or inflammation of the eyes, which can lead to increased sensitivity to light (photophobia) and vision impairment.
[Learn More in MedlinePlus]
Related Codes
ICD Code | Description | Valid for Submission |
---|---|---|
L51 | Erythema multiforme | NON-BILLABLE CODE |
L51.0 | Nonbullous erythema multiforme | BILLABLE CODE |
L51.2 | Toxic epidermal necrolysis [Lyell] | BILLABLE CODE |
L51.3 | Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome | BILLABLE CODE |
L51.8 | Other erythema multiforme | BILLABLE CODE |
L51.9 | Erythema multiforme, unspecified | BILLABLE CODE |
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)